Global Intravenous Immunoglobulin (IVIg) Market Report 2017

With the slowdown in world economic growth, the Intravenous Immunoglobulin (IVIg) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Intravenous Immunoglobulin (IVIg) market size to maintain the average annual growth rate of 8.46% from 5800.00 million $ in 2013 to 7400.00 million $ in 2016, Market analysts believe that the next few years, Intravenous Immunoglobulin (IVIg) market size will be further expanded, we expect that by 2021 , The market size of the Intravenous Immunoglobulin (IVIg) will reach 10500 million $.

Section 1: Free——Definition

Section (2 3): 1200 USD——Manufacturer Detail (Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang,)

Section 4: 900 USD——Region Segmentation (United States, Canada, South America, China, Japan, India, Korea, Germany, UK, France, Italy, Europe, Middle East, Africa, GCC)

Section (5 6 7): 500 USD——Product Type (IVIg Liquid, IVIg Powder, , , ), Industry(Immunodeficiency, Autoimmune Disease, Acute Infection, , ) and Channel (Direct Sales, Distributor) Segmentation

Section 8: 400 USD——Trend (2017-2021)

Section 9: 300 USD——Product Type Detail

Section 10: 700 USD——Downstream Consumer

Section 11: 200 USD——Cost Structure

Section 12: 500 USD——Conclusion